Ultra Long Acting Insulin Degludec Reduces Nocturnal Hypoglycemia

An investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.

Read more

Posted in Glucose & Insulin